Allison L Zulli

This inventor holds 30 USPTO granted patents and 8 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Cephalon, Inc., 89Bio, Inc., Venatorx Pharmaceuticals, Inc.. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Allison L Zulli. Retrieved from https://idiyas.com/inventor/allison-l-zulli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 30 (Patent Applications = 8)

% Patents Active = 83.3

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 10 (Patent Applications = 15)

Average Co-Inventor Count = 6.8

ph-index = 6

Forward Citations = 74(Granted Patents)

Location History:

Wayne, PA (US) (2007 - 2023)
Chesterbrook, PA (US) (2019 - 2024)

Company Filing History:

Venatorx Pharmaceuticals, Inc.

patents

4. 3 out of 269

Cancer Research Technology Limited

where one patent can have more than one assignee

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

Beta-Lactamase Inhibitors

Piperidine Derivatives

Atypical Protein Kinase C

Spiropiperidine Derivatives

Multicyclic Compounds

H3 Receptor Ligands

Fused Pyrrolocarbazoles

Aryl Pyridazinone Derivatives

Pyridazinone Derivatives

Azaquinazoline Inhibitors

Penicillin-Binding Protein Inhibitors

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12559509 - Citrate coordination complex of an orally-delivered beta-lactamase inhibitor and uses thereof (2026-02-24),

2. 12448392 - Spiropiperidine derivatives (2025-10-21),

3. 12173018 - Penicillin-binding protein inhibitors (2024-12-24),

4. 12098130 - 1,4-substituted piperidine derivatives (2024-09-24),

5. 11878982 - Spiropiperidine derivatives (2024-01-23),

6. 11702388 - 1,4-substituted piperidine derivatives (2023-07-18),

7. 11332485 - Penicillin-binding protein inhibitors (2022-05-17),

8. 11046707 - Spiropiperidine derivatives (2021-06-29),

9. 10851057 - 1,4-substituted piperidine derivatives (2020-12-01),

10. 10464952 - Beta-lactamase inhibitors (2019-11-05),

11. 10414763 - Azaquinazoline inhibitors of atypical protein kinase C (2019-09-17),

12. 10221135 - 1,4-substituted piperidine derivatives (2019-03-05),

13. 9914731 - Pyrazolo[1,5-a]pyridine derivatives and methods of their use (2018-03-13),

14. 9914730 - Azaquinazoline inhibitors of Atypical protein Kinase C (2018-03-13),

15. 9902696 - 1,4-substituted piperidine derivatives (2018-02-27),

Sure, I can help you with that article. Here is the structured article about inventor Allison L Zulli:

Title: The Innovation Journey of Allison L Zulli

Introduction: Allison L Zulli, a talented inventor hailing from Wayne, PA in the US, has made remarkable contributions in the field of pharmaceuticals with her innovative patents.

Latest Patents: One of her latest patents involves Spiropiperidine derivatives, compounds that act as fatty acid synthase inhibitors. These compounds have shown promising results in treating diseases mediated by fatty acid synthase. Another notable patent is on 1,4-substituted piperidine derivatives, also effective as fatty acid synthase inhibitors.

Career Highlights: Allison L Zulli has a portfolio of 26 patents, each showcasing her dedication to advancing pharmaceutical research. She has worked with renowned companies such as Cephalon, Inc. and 89bio, Inc., where she has brought her inventive ideas to life.

Collaborations: Throughout her career, Allison has collaborated with distinguished coworkers like Robert L Hudkins and Nadine C Becknell, forming strong teams that have propelled her inventions to success.

Conclusion: Allison L Zulli stands as a beacon of innovation in the pharmaceutical industry, with her patents paving the way for novel treatment methods. Her dedication to research and collaborations highlight her as a pioneering inventor in the field.

Profile summary based on public USPTO records.